Dengue vaccines and antiviral drug (in present, 2023-11-07)
관리자
0
54
11.09 15:48
- Sanofi in Paris
- 60% overall efficacy for the infected people
- Takeda in Osaka, Japan
- Overall efficacy rate of 73%
- Lower efficacy against DENV-3, and DENV-4 inconclusive.
- US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland
- Testing by the Butantan Institute in São Paulo, Brazil ( > 16,000 participants)
- Overall efficacy, 80%
- Janssen in Beerse, Belgium
